Clinical Trial Update: Exair® Versus Native Tissue Repair for Prolapse

View source ↗

Summary

A clinical trial comparing Exair® versus native tissue repair for pelvic organ prolapse has been terminated. The sponsor is Coloplast A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Organ Prolapse

Snippet

Sponsor: Coloplast A/S | Conditions: Pelvic Organ Prolapse | Status: TERMINATED